Skip to content
Review

ESC vs. ACC/AHA Guidelines for Non-Invasive Imaging in Chronic Coronary Disease: Guideline Discordance, Gaps, and Future Directions.

Sep 2026 · European Heart Journal-Cardiovascular Imaging · 0 citations
Medicine

TL;DR

The latest ESC guideline remains more diagnosis-forward and algorithmic, whereas the ACC/AHA guideline is more management-forward and symptom-driven, which may influence imaging selection, repeat testing, and evaluation of non-obstructive coronary syndromes.

Abstract

Aims

Chronic coronary disease remains a complex condition for which non-invasive imaging is central to diagnosis, risk stratification, follow-up, and management. An understanding of contemporary clinical practice guidelines is critical to appropriate test selection, avoidance of low-value testing, and individualized care. This review compares the contemporary European Society of Cardiology guidelines and the American College of Cardiology/American Heart Association guidelines regarding non-invasive imaging for chronic coronary disease/syndromes.

Methods

AND

Results

The European and American guidelines are broadly concordant in supporting clinical likelihood assessment before testing, selective use of coronary computed tomography angiography (CCTA) and functional imaging, and avoidance of routine surveillance testing in clinically stable patients. However, several distinctions emerge. First, the European guideline provides a more prescriptive diagnostic algorithm for suspected chronic coronary syndromes, using pre-test likelihood thresholds to guide deferral of testing, CCTA, functional imaging, and invasive angiography, whereas the American guideline is more focused on established chronic coronary disease, symptom change, functional decline, and whether testing will alter management. Second, the European guideline assigns a stronger early role to CCTA, particularly in low-to-moderate likelihood patients, and provides more high-risk anatomic and ischemic imaging thresholds. Third, the guidelines differ in the positioning of exercise electrocardiography and in the diagnostic evaluation of angina or ischemia with non-obstructive coronary arteries, microvascular angina, and vasospastic angina.

Conclusion

The latest ESC guideline remains more diagnosis-forward and algorithmic, whereas the ACC/AHA guideline is more management-forward and symptom-driven. These differences may influence imaging selection, repeat testing, and evaluation of non-obstructive coronary syndromes.

View source

Similar papers

Open access Sep 2026

Comparison of Risk Assessment Strategies Recommended by the 2019 and 2024 European Society of Cardiology Guidelines in Patients With Stable Chest Pain: A Coronary Computed Tomography Angiography Study

Background: The European Society of Cardiology issued guidelines in 2019 and 2024 to help clinicians determine whether patients with stable chest pain (SCP) require advanced cardiovascular imaging testing (CIT). This study aimed to compare the safety and effectiveness of these evaluation strategies. Methods: A total of...

Han-Tao Jiang, Chang Liu, Chao Zhang et al. · 0 citations
Aug 2026

The DiagnOsis of MINOCA (DOMINO) registry: a real-world use of multimodality imaging and its impact on etiologic classification.

Advanced diagnostic testing was associated with a higher likelihood of a determined etiologic diagnosis in MINOCA, despite marked international variability in its use; however, this association is partly definitional, as advanced testing directly contributes to diagnostic ascertainment for several etiologic categories.

D. Morrone, M. Alberti, J. Cravo et al. · 0 citations
Review Open access Sep 2026

Moderate aortic stenosis: diagnostic pitfalls and the role of multimodality imaging in risk stratification and clinical management

Moderate aortic stenosis (AS) has traditionally been considered a transitional and relatively benign stage of valvular disease. Yet, contemporary evidence shows that it is associated with substantial morbidity and mortality even before progression to severe AS. This paper synthesizes current evidence on the limitations...

G. Santangelo, A. Maloberti, C. Tognola et al. · 0 citations
Review Open access Sep 2026

From Guidelines to Ground Reality: The Underutilization of Stress Cardiac MRI in Ischemic Heart Disease - A Narrative State-of-the-Art Review.

Bridging the implementation gap for stress CMR will require coordinated efforts in education, infrastructure investment, policy reform, and targeted dissemination to ensure broader, equitable integration of this clinically valuable tool.

O. Abdelhai, Wael Aljaroudi, Musa A. Sharkawi et al. · 0 citations
Open access Oct 2026

A multi-biomarker approach for discrimination of angiographically detected coronary artery disease in metabolic dysfunction-associated steatotic liver disease: the utility of routine laboratory indices

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a globally prevalent chronic liver disease. Accumulating evidence indicates that MASLD is closely linked to coronary artery disease (CAD) through the liver-heart axis, with insulin resistance, chronic systemic inflammation and lipid disorders as...

Zhi-Ying Zhang, Jing-Tao Ma, Jie Huang · 0 citations
Review Open access Sep 2026

Clinical Applications of Cardiac Magnetic Resonance Imaging in Cardiology. Consensus Statement of the Eurasian Association of Cardiologists (EAC) (2026)

This consensus document summarizes the current role of cardiovascular magnetic resonance (CMR) in contemporary cardiology practice. It integrates the latest evidence, international guideline recommendations, and practical experience regarding the use of CMR in the diagnosis and management of the most common cardiovascu...

O. Stukalova, S. Aleksandrova, T. Dautov et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.